FDA Inspection
Blood Assurance IncBlood Assurance Inc – FDA Inspection, Feb 17, 2026
Record Details
This FDA Inspection record concerns Blood Assurance Inc, with an inspection on February 17, 2026, issued by the New Orleans District Office, covering biologics.
View Company Profile
ID · 5fe01f65-aa6b-4498-ba0e-4a9141d6e55c
Inspection Facts
- Inspection number
- 1303202
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 630.10(h)Ineligible Donor
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blood Assurance Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| October 24, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 12, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 28, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 13, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 18, 2011 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Blood Assurance Inc
- FDA Inspection 1187433 - 2022-10-24
- FDA Inspection 1069809 - 2018-09-12
- FDA Inspection 940145 - 2015-08-28
- FDA Inspection 844018 - 2013-08-13
- FDA Inspection 735419 - 2011-07-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.